Ocata Therapeutics Inc fka OCAT

[rocky301]

UPDATE CIRM: RABIN RESPONSE

It seemed a natural and obvious fit that the CIRM 10-03(funding for clinical trials) would have been where ACT applied. I spent time on this yesterday and found no evidence that we applied or were in the hunt for this RFA with a meeting set for tomorrow on this funding. I went to the source and have the e-mail posted below with permission to repost here.

RFA 10-03: CIRM TARGETED CLINICAL DEVELOPMENT AWARDS
http://www.cirm.ca.gov/files/grants/...nded.10.15.pdf
__________________________________________________

From: Rocky [mailto:[e-mail]]
Sent: Tuesday, May 03, 2011 10:56 AM
To: Gary Rabin
Subject: CIRM

Mr. Rabin,

In the March CC you mentioned CIRM and application of about $4MM.
I was assuming the application would be under the following:
RFA 10-03: CIRM Targeted Clinical Development Awards

Tomorrow a meeting is being held with this being part of agenda,
8. Consideration of recommendations from Grants Working Group regarding applications submitted in response to RFA 10-03: CIRM Targeted Clinical Development Awards

The only recommendation on CIRM site is the following which is GERON for just under $25MM
Summary of application CT1-05168 | California Institute for Regenerative Medicine

Is the RFA 10-03 where ACT applied? or was it under some other funding opportunity?
Thanks for any help/guidance on this issue...

Rock

Hi Rocky,

The CIRM funding RFA that we are interested in has an October deadline. Apologize for any confusion. The October round is the corporate funding RFA that carries with it the set of restrictions that would be palatable to our clinical partners. Can't fit a square peg in a round hole....
Nice to hear from you. We are so busy getting ready for trials and all of the other corporate activities.
Best,
Gary